Maryam Sarbishegi

Maryam Sarbishegi

Auto-generated profile, based on publicly available information

Maryam Sarbishegi

Cellular and Molecular Research Center and Department of Anatomy, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2017 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
MSMaryam Sarbishegi
Maryam Sarbishegi
EGEnam Alhagh Charkhat Gorgich
Enam Alhagh Charkhat Gorgich
OKOzra Khajavi
Ozra Khajavi
GKGholamreza Komeili
Gholamreza Komeili
SSSaeedeh Salimi
Saeedeh Salimi

9 January 2016 in Nephro-Urology Monthly
Verified
Journal Article
Open access
PDF file
MSMaryam Sarbishegi
Maryam Sarbishegi
MKMohaddeseh Khani
Mohaddeseh Khani
SSSaeedeh Salimi
Saeedeh Salimi
MVMohharam Valizadeh
Mohharam Valizadeh
FAFereydoon Sargolzaei Aval
Fereydoon Sargolzaei Aval
Background: Benign prostate hyperplasia (BPH) is a common urological disorder in elderly men. Phytotherapy is frequently used to alleviate the symptoms of this condition. Objectives: The present study investigated the effect of Withania coagulans extract (WCE), which is known to have antioxidant, anti-inflammatory, antihyperglycemic, and anti-cancer properties, on testosterone-induced BPH in rats. Materials and Methods: Forty Wistar rats were divided into five groups (each n = 8): the control group, the untreated BPH group, and three WCE-treated groups (WCE250, 500, and 1000). BPH was induced with 3 mg/kg subcutaneous injections of testosterone propionate for four weeks. WCE was concomitantly administrated by oral gavage. At the end of the induction schedule, the animals were sacrificed and their prostate glands were dissected, weighed, and fixed for histological examination (H&E and proliferating cell nuclear antigen [PCNA] staining). Half of each sample was prepared for measurement of malondialdehyde (MDA) and total antioxidant capacity (TAC) levels in the prostate. Results: The present study revealed that BPH caused elevation of MDA levels, suppression of TAC levels, and increased PCNA expression in the prostate gland. Interestingly, in a dose-dependent manner, WCE caused decreased MDA levels and increased TAC levels in the prostate gland, compared to the untreated BPH group. Histopathological examinations showed a reduction in PCNA expression in the prostate epithelium of the WCE animals. Conclusions: W. coagulans inhibits the development of BPH can be useful for the treatment of this condition. Keywords: Benign Prostatic Hyperplasia; Proliferating Cell Nuclear Antigen, Rats; Withania coagulans

SASolmaz Alizadehmoghaddam
Solmaz Alizadehmoghaddam
FPFereshteh Pourabdolhossein
Fereshteh Pourabdolhossein
HNHossein Najafzadehvarzi
Hossein Najafzadehvarzi
MSMaryam Sarbishegi
Maryam Sarbishegi
Kiarash SalekiKiarash Saleki
Kiarash Saleki
HNHamid Reza Nouri
Hamid Reza Nouri
The underlying mechanisms of inflammasome activation and the following dopaminergic neuron loss caused by chronic neuroinflammation remain entirely unclear. Therefore, this study aimed to investigate the impact of crocin on the inflammasome complex within an experimental model of Parkinson's disease (PD) using male Wistar rats. PD was induced by the stereotaxic injection of lipopolysaccharide (LPS), and crocin was intraperitoneally administrated one week before the lesion, and then treatment continued for 21 days. Open field (OF) and elevated plus maze tests were applied for behavioral assays. Furthermore, hematoxylin and eosin (H&E) and immunostaining were performed on whole brain tissue, while dissected substantia nigra (SN) was used for immunoblotting and real-time PCR to evaluate compartments involved in PD. The time spent in the center of test was diminished in the LPS group, while treatment with 30 mg/kg of crocin significantly increased it. H&E staining showed a significant increase in cell infiltration at the site of LPS injection, which was ameliorated upon crocin treatment. Notably, crocin-treated animals showed a reduced number of caspase-1 and IL-1β positive cells, whereas the number of positive cells was increased in the LPS group (P < 0.05). A significant decrease in tyrosine hydroxylase (TH) expression was also found in the LPS group, while crocin treatment significantly elevated its expression. IL-1β, IL-18, NLRP1, and AIM2 genes expression significantly increased in the LPS group. On the other hand, treatment with 30 mg/kg of crocin significantly downregulated the expression levels of these genes along with NLRP1 (P < 0.05). In summary, our findings suggest that crocin reduces neuroinflammation in PD by diminishing IL-1β and caspase-1 levels, potentially by inhibiting the expression of AIM2 and NLRP1 genes.

1 July 2021 in Behavioural Brain Research
Verified
Journal Article
Closed access
EGEnam Alhagh Charkhat Gorgich
Enam Alhagh Charkhat Gorgich
HPHouman Parsaie
Houman Parsaie
SYSazin Yarmand
Sazin Yarmand
FBFarzaneh Baharvand
Farzaneh Baharvand
MSMaryam Sarbishegi
Maryam Sarbishegi

24 August 2016 in Nephro-Urology Monthly
Verified
Journal Article
Open access
PDF file
MSMaryam Sarbishegi
Maryam Sarbishegi
OKOzra Khajavi
Ozra Khajavi
MAMohammad Reza Arab
Mohammad Reza Arab
Background: Phytotherapy is a popular treatment option in cases of benign prostatic hyperplasia (BPH), with many different herbal products being used for the treatment of this condition. Withania coagulans (WC) is an herbal medicine that has shown anti-tumoral, anti-inflammatory, and antioxidant effects. Objectives: This study examined the effect of Withania coagulans extract (WCE) on prostatic cell apoptosis and cyclooxygenase-2 (COX-2) expression in cases of benign prostatic hyperplasia (BPH) in rats. Methods: Forty Wistar rats were equally divided into five groups: control, sham, BPH, BPH + WCE, and BPH + CLX (celecoxib) as a positive control group. The induction of BPH was achieved via the subcutaneous injection of 3 mg/kg of testosterone propionate (TP) daily for 28 days. The animals received WCE, celecoxib, or distilled water by oral gavage accompanied by the TP injection. After four weeks, the prostate glands of the rats were weighed to measure the prostatic index (PI). The ventral lobes of the prostates were dissected and processed with paraffin blocks in order to study the number of mast cells. A TUNEL analysis was performed to evaluate the cell apoptosis, while the expression of COX-2 was examined using immunohistochemistry. Results: BPH was obvious in the ventral lobe of the prostate, and the administration of WCE markedly decreased the PI and the number of mast cells (P < 0.001) in the BPH rats. Additionally, the WCE treatment induced prostatic cell apoptosis when compared to the BPH group. Furthermore, following the WCE treatment, the expression of COX-2 in the prostatic tissues was significantly decreased when compared to the BPH groups. Conclusions: According to the results of this study, WCE was effective in the treatment of BPH in rats. It may therefore have beneficial effects in the treatment of patients with BPH. Keywords: Benign Prostatic Hyperplasia; Withania coagulans; Apoptosis; Cyclooxygenase-2

MSMaryam Sarbishegi
Maryam Sarbishegi
EGEnam Alhagh Charkhat Gorgich
Enam Alhagh Charkhat Gorgich
Parkinson’s disease (PD) is one of the most common neurodegenerative movement-related disturbance characterized by the degeneration of dopaminergic neurons with uncertain underlying mechanisms, which can be modeled by the rotenone (ROT). Neuroinflammation and oxidative stress (OS) are the most possible hypotheses to create this condition.The aim of this study was to evaluate the effects of celecoxib (CLX) on ROT-induced rat model of PD. To this aim, the suppression of neuroinflammation and oxidative stress-mediated apoptosis was surveyed.In this experimental study, thirty-two male Sprague-Dawley rats randomly classified into 4 groups (n = 8 rats/group) in the following order: control, sham, PD (2.5 mg/kg/48 hours ROT subcutaneously), CLX + PD (20 mg/kg/24 daily orally CLX + 2.5 mg/kg/48 hours ROT). After 28 days of the experiment, the rats were sacrificed and their brain was removed. Then histological (Nissl staining) and biochemical assessments (total antioxidant capacity (TAC) were carried out and malondialdehyde (MDA) levels were measured. The data were analyzed by ANOVA test.The biochemical assessments showed TAC was significantly increased in CLX + PD group compared with PD group, whereas MDA was decreased in CLX + PD group compared with PD group (P < 0.01). We found a significant decrease in the number of dopaminergic cells in substantia nigra pars compacta (SNc) in PD group (P < 0.001), and treatment with CLX markedly increased dopaminergic neurons in CLX + PD compare to PD group (P < 0.01). The findings of this study revealed that CLX treatment can effectively improve the antioxidant defense system and attenuates striatum insults on ROT-induced rat model of PD. These findings suggest that CLX plays a neuroprotective role in the inhibition of oxidative stress and neuroinflammation.